Skip to content

FARMAFRANCE

Active Private limited company (pre-2019)founded 2008active for 17 yearsBeestenmarkt 19, 1500 HalleKBO/BCE: BE 0808.677.221

Lifetime

17 annual accounts with figures on one time axis
peak of €607,443 in 2025
€607,443▲ 8.0%
lowest -€10,911 in 2017
€151,312▲ 56.4%
peak of €911,749 in 2025
€911,749▲ 19.9%
€469,437▼ 28.5%
peak of 6.3 FTE in 2017
-not published
Board3 names since 2013
2 directors and 1 other
Documentsfilings and deeds
25-07-20266 days before the deadline
2025micro format
Result from €96,733 to €151,312Equity from €760,437 to €911,749Debts from €656,185 to €469,437

Key points

from the 2025 annual accounts

Equity

€911,749 ▲ 19.9%

FARMAFRANCE has made a profit without a break since 2018.

Result

€151,312 ▲ 56.4%
€96,7002024€151,0002025

The result rose in 2025 from €96,733 to €151,312.

Turnover

≈ €2.2m estimated

The accounts state no turnover.

Liquidity

2.22 was 1.56 in 2024

Short-term debts fell from €655,203 to €463,519.

Filings

17 annual accounts since 2009
AprilJune31 JulyOctober2010201520202025

Two of the last ten came late. The 2018 accounts came in latest, 47 days after the end of the period.

Position in the sector

€151,312

Higher net result than 95% of companies in retail trade. The sector median is €4,724, over 25,359 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 17,816 companies had the same profile as FARMAFRANCE has now. Each dot stands for 45 companies, two years later.

96.5%
were still trading
3.2%
stopped another way
0.3%
went bankrupt
  • Small
  • 10 to 20 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,965 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 17,816 companies, not a prediction for FARMAFRANCE. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Manager
Director
  • 1,274 sharesdeed of 23-01-2014
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0808677221
changes role from manager to director “Iedere handelsbedrijvigheid die met gezondheidszorg verband houdt; Scheikundige, farmaceutische en…” (deed in Dutch) · Discharge granted to (manager) · Gazette deed
New establishment in Soignies Rue Neuve 9
Capital increase The capital rose from €18,600 to €218,600, with 1,176 new shares · The capital rose from €218,600 to €235,250, with 98 new shares · General meeting of 24-12-2013 · Gazette deed
All 31 events

Comparable companies

same main activity, similar in size and age
Company
FARMAFRANCE Halle €1.4m €607,443 66.0% -
GLOBAL-E-CARE Antwerp €1.4m €639,834 -8.2% 3.5
APOTHEEK VAN ALSENOY Kapellen €1.3m €578,582 28.8% 4.5
APOTHEEK VANDEBROEK Bruges €1.3m €555,654 36.2% 1.5
APOTHEEK VAN BRITSOM Beveren-Kruibeke-Zwijndrecht €1.3m €597,067 59.4% 1.6
APOTHEEK VERYSER-VERHAEGHE Lede €1.3m €554,164 40.9% 0
PDV IMMO Sambreville €1.4m €539,657 35.7% 1.9

These companies have the same main activity as FARMAFRANCE: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €1.3m and €1.4m, founded between 2007 and 2010.

Official details

Source: KBO
Status
Active since 24-12-2008Normal situation
Activity
Retail sale of pharmaceutical productsNACE 47730and 2 others
Establishment units
2.175.470.8641500 Halle, since 19-12-2008
2.268.087.9491502 Halle, since 18-01-2009and 1 other
Financial year end
31 December
Peppol
Reachable since 26-11-2025
Company details

Annual accounts 2025

€1.4m▼ 2.5%
Filing
Filed on 25-07-2026, 6 days before the end of the filing period
Financials

Insights on FARMAFRANCE

FARMAFRANCE files the micro format. That format states no turnover. The gross margin rose from €470,404 in 2009 to €607,443 in 2025.

The balance sheet grew most from 2022 to 2024 through fixed assets.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about FARMAFRANCE

What is the company number of FARMAFRANCE?
The company number of FARMAFRANCE is 0808.677.221. The VAT number is the same number with BE in front: BE 0808.677.221.
Where is FARMAFRANCE based?
The registered office is at Beestenmarkt 19, 1500 Halle.Company details
What does FARMAFRANCE do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of FARMAFRANCE?
FARMAFRANCE is a private limited company (pre-2019) (BVBA).
When was FARMAFRANCE founded?
FARMAFRANCE was founded on 24-12-2008.
Is FARMAFRANCE still active?
Yes, FARMAFRANCE is an active enterprise in the KBO register.
How many employees does FARMAFRANCE have?
FARMAFRANCE had an average of 5.1 full-time equivalents in financial year 2021, according to the filed annual accounts.Financials
What is the turnover of FARMAFRANCE?
The turnover in financial year 2025 is about €2.2m. This figure is estimated from the gross margin of €607,443 and 67 comparable companies (NACE 477). It probably lies between €1.6m and €3.4m.
Is FARMAFRANCE profitable?
In financial year 2025, FARMAFRANCE made a profit of €151,312.
Where can I find the annual accounts of FARMAFRANCE?
FARMAFRANCE filed 17 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of FARMAFRANCE due?
FARMAFRANCE must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.